HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masato Kanazawa Selected Research

Cerebral Infarction

7/2015Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masato Kanazawa Research Topics

Disease

14Ischemic Stroke
11/2024 - 03/2011
10Brain Ischemia (Cerebral Ischemia)
10/2020 - 06/2011
9Stroke (Strokes)
11/2023 - 01/2017
7Ischemia
07/2022 - 06/2011
3Infarction (Infarctions)
01/2023 - 01/2014
3Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
11/2021 - 01/2019
3Neuroinflammatory Diseases
03/2017 - 07/2015
3Hemorrhage
11/2015 - 06/2011
2Cerebral Small Vessel Diseases
11/2023 - 12/2022
2Atherosclerosis
09/2021 - 10/2004
2Edema (Dropsy)
01/2018 - 05/2012
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
04/2016 - 07/2015
2hypoglycemic encephalopathy
01/2015 - 08/2013
2Hypoglycemia (Reactive Hypoglycemia)
01/2015 - 08/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2011 - 03/2007
1Type 2 Diabetes Mellitus (MODY)
11/2023
1Muscle Weakness
06/2023
1Polyradiculoneuropathy (Polyradiculoneuritis)
06/2023
1Hypoxia (Hypoxemia)
01/2023
1Lacunar Stroke
09/2021
1Hypertension (High Blood Pressure)
12/2020
1Transient Ischemic Attack
12/2020
1Inflammation (Inflammations)
12/2020
1Intracranial Arterial Diseases
01/2020
1Vascular Remodeling
03/2017
1Spinal Cord Diseases
02/2016
1Brain Injuries (Brain Injury)
07/2015
1Cerebral Infarction
07/2015
1Coma (Comas)
01/2015
1Hyperglycemia
01/2015
1Brain Edema (Cerebral Edema)
01/2014
1Fever (Fevers)
01/2014
1Paresis (Hemiparesis)
01/2014
1Multiple Myeloma
01/2014
1Cerebral Hemorrhage
05/2012
1TDP-43 Proteinopathies
03/2011
1Chorea (Rheumatic Chorea)
09/2007
1Apraxias (Dyspraxia)
03/2007
1Blepharospasm
03/2007
1Leukocytosis (Pleocytosis)
07/2005
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
10/2004
1Mixed Connective Tissue Disease (MCTD)
10/2004
1Vascular Malformations
08/2004

Drug/Important Bio-Agent (IBA)

8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 06/2011
7Glucose (Dextrose)FDA LinkGeneric
01/2023 - 05/2012
6Oxygen (Dioxygen)IBA
01/2023 - 05/2012
6Tissue Plasminogen Activator (Alteplase)FDA Link
12/2020 - 06/2011
3GadoliniumIBA
06/2023 - 08/2004
3Proteins (Proteins, Gene)FDA Link
11/2021 - 07/2005
3High-Temperature Requirement A Serine Peptidase 1IBA
11/2021 - 01/2019
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2019 - 06/2011
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2019 - 06/2011
3ProgranulinsIBA
03/2017 - 07/2015
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2023 - 01/2015
2Neuroprotective AgentsIBA
11/2023 - 01/2015
2Peptide Hydrolases (Proteases)FDA Link
12/2022 - 05/2012
2Therapeutic UsesIBA
10/2020 - 07/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2019 - 01/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016 - 07/2015
2Interleukin-10 (Interleukin 10)IBA
04/2016 - 07/2015
2DNA (Deoxyribonucleic Acid)IBA
07/2015 - 03/2011
1Metformin (Glucophage)FDA LinkGeneric
11/2023
1Antiviral Agents (Antivirals)IBA
06/2023
1stage-specific embryonic antigen-3 (GL-X)IBA
01/2023
1Serine (L-Serine)FDA Link
12/2022
1Glutamic Acid (Glutamate)FDA Link
07/2022
1TEMPOIBA
07/2022
1candesartanIBA
11/2021
1Antihypertensive Agents (Antihypertensives)IBA
09/2021
1Protective AgentsIBA
12/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020
1Laminin (Merosin)IBA
01/2020
1nilotinibFDA Link
01/2020
1IntegrinsIBA
01/2020
1Blood Proteins (Serum Proteins)IBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2016
1Cathepsin BIBA
11/2015
1Matrix Metalloproteinases (MMPs)IBA
11/2015
1Cathepsin LIBA
11/2015
1Glycoproteins (Glycoprotein)IBA
07/2015
1Angiopoietin-1IBA
01/2014
1Hemoglobins (Hemoglobin)IBA
01/2014
1Lactic Acid (Lactate)FDA LinkGeneric
08/2013
1Fibronectins (Fibronectin)IBA
05/2012
1VitronectinIBA
05/2012
1AntigensIBA
05/2012
1Haloperidol (Haldol)FDA LinkGeneric
09/2007
1Type A Botulinum Toxins (Botox)FDA Link
03/2007
1Muramidase (Lysozyme)IBA
07/2005
1AutoantibodiesIBA
10/2004
1oxidized low density lipoproteinIBA
10/2004
1Malondialdehyde (Propanedial)IBA
10/2004
1AntibodiesIBA
10/2004
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2004

Therapy/Procedure

10Therapeutics
11/2024 - 01/2014
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 01/2017
1Thrombectomy
12/2020
1General Anesthesia
12/2020
1Drug Therapy (Chemotherapy)
01/2014
1Injections
03/2007